XNCR CIK: 1326732

Xencor Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
424
FY22:
675
FY23:
636
FY24:
578
FY25:
600
(positive)
Change from FY21 to FY25
millions USD
FY21:
414
FY22:
171
FY23:
330
FY24:
374
FY25:
276
Total assets
Change from FY21 to FY25
millions USD
FY21:
838
FY22:
846
FY23:
965
FY24:
952
FY25:
875

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
70.7
FY22:
63.8
FY23:
73.9
FY24:
87.4
FY25:
95.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
34.0
FY22:
54.9
FY23:
229
FY24:
190
FY25:
144
(positive)
Change from FY21 to FY25
millions USD
FY21:
734
FY22:
727
FY23:
662
FY24:
678
FY25:
636
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
838
FY22:
846
FY23:
965
FY24:
–
FY25:
875

All amounts in millions USD Data source:SEC EDGAR